749 Early phase oncology experience on the use of an oncolytic adenovirus encoding for TNFa and IL-2 for the treatment of solid tumors – Interim results

• Marco Donia,
• Tuomo Alanko,
• Akseli Hemminki,
• Víctor Cervera-Carrascón,
• João Santos,
• Riikka Havunen,
• Eva Ellebaek,
• Brigitte Dreno,
• Inge Svane,
• Amir Khammari,
• Juha Kononen,
• Jorma Sormunen,
• Katriina Peltola,
• Riitta Korpisaari,
• Susanna Juteau,
• Marjut Jaakkola,
• Tine Monberg,
• Suvi Sorsa,
• Santeri A Pakola,
• James Clubb,
• Elise Jirovec,
• Dafne CA Quixabeira,
• Tatiana Kudling,
• Lyna Haybout,
• Claudia Kistler

Affiliations

Marco Donia

3National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark

Tuomo Alanko

4Docrates Cancer Center, Helsinki, Finland

Akseli Hemminki

1TILT Biotherapeutics, Helsinki, Finland

Víctor Cervera-Carrascón

2Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

João Santos

1Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

Riikka Havunen

2TILT Biotherapeutics Ltd, Helsinki, Finland

Eva Ellebaek

7Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark

Brigitte Dreno

8Department of Dermatology, Nantes university, CHU Nantes, CIC 1413, Inserm INCIT, Nantes, France

Inge Svane

3National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark

Amir Khammari

8Department of Dermatology, Nantes university, CHU Nantes, CIC 1413, Inserm INCIT, Nantes, France

Juha Kononen

4Docrates Cancer Center, Helsinki, Finland

Jorma Sormunen

4Docrates Cancer Center, Helsinki, Finland

Katriina Peltola

3Comprehensive Cancer Centre, Helsinki, Finland

Riitta Korpisaari

4Docrates Cancer Center, Helsinki, Finland

Susanna Juteau

6Helsinki University Hospital, Helsinki, Finland

Marjut Jaakkola

4Docrates Cancer Center, Helsinki, Finland

Tine Monberg

7Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark

Suvi Sorsa

1TILT Biotherapeutics, Helsinki, Finland

Santeri A Pakola

5University of Helsinki, Helsinki, Finland

James Clubb

9TILT Biotherapeutics, Helsinki, Finland

Elise Jirovec

2Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

Dafne CA Quixabeira

2Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

Tatiana Kudling

1Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

Lyna Haybout

1TILT Biotherapeutics, Helsinki, Finland

Claudia Kistler

1TILT Biotherapeutics, Helsinki, Finland